ema semaglutide naion june 2025 The Effect of and GLP-1 RAs on Risk of Nonarteritic Anterior Ischemic Optic Neuropathy 🚨 New Study Alert 🚨

Throughout the year, Trump has teased triple-digit tariffs unless pharma companies make significant investments in the U.S., and has also waged a war on high drug prices for Americans

The agency's recommendation is conditional, meaning the benefits likely outweigh the downsides but more evidence is needed

It's important to note that the study was small and the patients were mostly white and privately insured, meaning the results may not apply to everyone

Timeline GLP-1 results occur gradually over several months

Tirzepatide produces more weight loss than semaglutide, but individualized dosing with robust support can achieve similar outcomes using lower doses